These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 7308496)

  • 1. Calcium entry blockers and vascular smooth muscle heterogeneity.
    Van Nueten JM; Vanhoutte PM
    Fed Proc; 1981 Dec; 40(14):2862-5. PubMed ID: 7308496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of action of calcium entry blockers.
    Godfraind T
    Fed Proc; 1981 Dec; 40(14):2866-71. PubMed ID: 7308497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium and alpha-adrenoceptors in activation of vascular smooth muscle.
    Vanhoutte PM; Rimele TJ
    J Cardiovasc Pharmacol; 1982; 4 Suppl 3():S280-6. PubMed ID: 6184553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of action of calcium antagonists on myocardial and smooth muscle membranes.
    Zakhari S
    Drugs Exp Clin Res; 1986; 12(9-10):817-29. PubMed ID: 3539569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Excitation-contraction coupling in cardiac and vascular smooth muscle: modification by calcium-entry blockade.
    McCall D
    Circulation; 1987 Jun; 75(6 Pt 2):V3-14. PubMed ID: 2436829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of binding of the Ca++ channel antagonist, [3H]nitrendipine, to guinea-pig ileal smooth muscle.
    Bolger GT; Gengo P; Klockowski R; Luchowski E; Siegel H; Janis RA; Triggle AM; Triggle DJ
    J Pharmacol Exp Ther; 1983 May; 225(2):291-309. PubMed ID: 6842393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium-entry blockers and vascular smooth muscle.
    Vanhoutte PM
    Circulation; 1982 Jan; 65(1 Pt 2):I11-9. PubMed ID: 7030518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitor effects of diltiazem, nicardipine, nifedipine and verapamil on the norepinephrine-induced contractions of the canine saphenous vein in calcium-free medium.
    Saïag B; Milon D; Bentue-Ferrer D; Allain H; Rault B; Van den Driessche J
    Res Commun Chem Pathol Pharmacol; 1994 Mar; 83(3):255-69. PubMed ID: 8008975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of calcium entry blockers and adenosine on the relaxation of large and small coronary arteries.
    Mustafa SJ; Askar AO
    Life Sci; 1986 Mar; 38(10):877-85. PubMed ID: 3951314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Inhibitory activity of D-600 on smooth vascular tissue: comparison with nifedipine, verapamil and diltiazem].
    Raddino R; Pelà G; Ferrari A; Ghirarduzzi A; Ferrari R
    Cardiologia; 1987 May; 32(5):469-72. PubMed ID: 3621257
    [No Abstract]   [Full Text] [Related]  

  • 11. Calcium entry blockers and receptor-response coupling.
    Godfraind T
    J Cardiovasc Pharmacol; 1982; 4 Suppl 3():S269-72. PubMed ID: 6184551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolated rat cardiac myocytes as an experimental model to study calcium overload: the effect of calcium-entry blockers.
    Donck LV; Pauwels PJ; Vandeplassche G; Borgers M
    Life Sci; 1986 Mar; 38(9):765-72. PubMed ID: 3951332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specificity of action of Ca++ entry blockers. A comparison of their actions in rat arteries and in human coronary arteries.
    Godfraind T; Miller RC
    Circ Res; 1983 Feb; 52(2 Pt 2):I81-91. PubMed ID: 6831654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular reactivity and calcium-entry blockers.
    Van Nueten JM; De Clerck F
    Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 17():575-83. PubMed ID: 6233852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of verapamil and flunarizine on epinephrine-induced vasoconstriction and on spontaneous vasomotion of arterioles in skeletal muscle in the rat in vivo.
    De Clerck F; Loots W; Voeten J; Janssen PA
    J Cardiovasc Pharmacol; 1989 Jan; 13(1):76-83. PubMed ID: 2468939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of calcium-entry blockers and divalent cations on noradrenaline-induced contractions of the rat anococcygeus muscle.
    Oriowo MA
    Arch Int Pharmacodyn Ther; 1984 Sep; 271(1):45-52. PubMed ID: 6497509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular actions and pharmacology of the calcium channel blocking drugs.
    Katz AM; Hager WD; Messineo FC; Pappano AJ
    Am J Med; 1984 Aug; 77(2B):2-10. PubMed ID: 6486125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute hypertension and calcium-channel blockers.
    Kanneganti M; Halpern NA
    New Horiz; 1996 Feb; 4(1):19-25. PubMed ID: 8689271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative evaluation of the Ca2+-antagonistic activity of some Bulgarian vasodilating agents and of known Ca2+-antagonists on K+-depolarized smooth muscle from guinea-pig taenia coli.
    Mutafova-Yambolieva V; Staneva-Stoytcheva D; Nikolov R
    Acta Physiol Pharmacol Bulg; 1989; 15(2):40-6. PubMed ID: 2801147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thromboxane A2-induced vascular endothelial cell damage and respiratory smooth muscle cell contraction: inhibition by flunarizine, a Ca2+-overload blocker.
    De Clerck F; Loots W; Somers Y; Van Gorp L; Verheyen A; Wouters L
    Arch Int Pharmacodyn Ther; 1985 Mar; 274(1):4-23. PubMed ID: 2990365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.